InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+23.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Aguilar Laura K., Directeur Médical. Officer active across 1 company, notably Candel Therapeutics, Inc.. Aggregated, 3 filings have been published. History available since 6 May 2022. The latest transaction was filed on 6 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
171,335 shares@ US$1.460.077% mcap100.0% of flowCommon StockSEC:0000899243-22-017477:0
56,096 sharesCommon StockSEC:0000899243-21-031088:0
56,096 sharesCommon StockSEC:0000899243-21-031088
3 of 3 declarations
About Aguilar Laura K.
Aguilar Laura K. is the Chief Medical Officer of Candel Therapeutics, Inc. She is responsible for leading the company's medical and clinical initiatives, bringing her expertise in biotechnology. Her role is crucial for the development of new treatments and therapies.
